Regulatory UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention PharmaTimesClesrovimab is first monoclonal antibody offering a single fixed dose for infantsInfectious DiseaseRead full story pharminent April 27, 2026 (Last updated: April 27, 2026) PharmaTimes Clesrovimab is first monoclonal antibody offering a single fixed dose for infants Infectious Disease Read full story Post navigation Previous: Sun Pharma to acquire Organon for $11.75bnNext: UK biotech could be bound for recovery, BIA report reveals Related Stories Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026 Regulatory HHS appoints permanent FDA CBER, CDER heads pharminent September 10, 2026 Regulatory FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer pharminent September 7, 2026